BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32175786)

  • 1. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
    Meacham PJ; Williams AM; Strawderman M; Baran AM; Archibald WJ; Wallace DS; Tschernia NP; Burack WR; Barr PM; Zent CS
    Leuk Lymphoma; 2020 Jul; 61(7):1636-1644. PubMed ID: 32175786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications.
    Parikh SA; Meacham PJ; Zent CS; Evans AG
    Leuk Lymphoma; 2020 May; 61(5):1037-1051. PubMed ID: 31928278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
    Czader M; Amador C; Cook JR; Thakkar D; Parker C; Dave SS; Dogan A; Duffield AS; Nejati R; Ott G; Xiao W; Wasik M; Goodlad JR
    Am J Clin Pathol; 2023 Jun; 159(6):554-571. PubMed ID: 37052539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
    Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
    Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Richter Syndrome in Chronic Lymphocytic Leukemia.
    Vitale C; Ferrajoli A
    Curr Hematol Malig Rep; 2016 Feb; 11(1):43-51. PubMed ID: 26830086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
    Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
    Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
    Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
    Rossi D; Spina V; Forconi F; Capello D; Fangazio M; Rasi S; Martini M; Gattei V; Ramponi A; Larocca LM; Bertoni F; Gaidano G
    Int J Cancer; 2012 Jun; 130(12):3006-10. PubMed ID: 21796624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
    J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.